PharmacoMicrobiology and PharmacoMicrobioResistance: Expanding the Paradigm of Drug-Microbe Interactions and Resistance Beyond Antimicrobials in the Pharmacosphere

Antimicrobial resistance (AMR) is framed as a defining global health crisis, yet its conceptual boundaries remain artificially narrow. By focusing primarily on antibiotics, current paradigms ignore a broader reality: microorganisms continuously respond to the full spectrum of human and animal pharmaceuticals in both patients and the environment. This oversight obscures critical dimensions of drug action and resistance mechanisms. We propose PharmacoMicrobiology (PM) and PharmacoMicrobioResistance (PMR) to redefine microbial–drug interactions beyond traditional antimicrobials, specifically accounting for multiple simultaneous drug exposures. Microbes actively transform, degrade, and resist diverse non-antibiotic drugs, potentially undermining therapeutic efficacy across multiple distinct medical fields. Shaped by environmental contamination, microbiome dynamics, and horizontal gene transfer, resistance to these non-antibiotic drugs may already be emerging entirely unnoticed. Ignoring this expanded resistome risks repeating past failures. Integrating PM and PMR into comprehensive One Health frameworks, powered by advanced artificial intelligence, is essential to anticipate, detect, and prevent drug resistance.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-16
DOI
https://doi.org/10.20944/preprints202611.1577.v1
Primary Topic
Pharmaceutical and Antibiotic Environmental Impacts
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

PharmacoMicrobiology and PharmacoMicrobioResistance: Expanding the Paradigm of Drug-Microbe Interactions and Resistance Beyond Antimicrobials in the Pharmacosphere

Jean‐Marc Rolain, Ghislaine Descours, Fadi Bittar, Fernando Baquero
Preprints.org
Pharmaceutical and Antibiotic Environmental Impacts
preprint

PharmacoMicrobiology and PharmacoMicrobioResistance: Expanding the Paradigm of Drug-Microbe Interactions and Resistance Beyond Antimicrobials in the Pharmacosphere

Jean‐Marc Rolain, Ghislaine Descours, Fadi Bittar, Fernando Baquero
preprint en

Abstract

Antimicrobial resistance (AMR) is framed as a defining global health crisis, yet its conceptual boundaries remain artificially narrow. By focusing primarily on antibiotics, current paradigms ignore a broader reality: microorganisms continuously respond to the full spectrum of human and animal pharmaceuticals in both patients and the environment. This oversight obscures critical dimensions of drug action and resistance mechanisms. We propose PharmacoMicrobiology (PM) and PharmacoMicrobioResistance (PMR) to redefine microbial–drug interactions beyond traditional antimicrobials, specifically accounting for multiple simultaneous drug exposures. Microbes actively transform, degrade, and resist diverse non-antibiotic drugs, potentially undermining therapeutic efficacy across multiple distinct medical fields. Shaped by environmental contamination, microbiome dynamics, and horizontal gene transfer, resistance to these non-antibiotic drugs may already be emerging entirely unnoticed. Ignoring this expanded resistome risks repeating past failures. Integrating PM and PMR into comprehensive One Health frameworks, powered by advanced artificial intelligence, is essential to anticipate, detect, and prevent drug resistance.

Preprints.org
Pharmaceutical and Antibiotic Environmental Impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon